These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26418094)

  • 1. [Cartography of psychoactive heterotopias: a look at the medical, legal and social discourses regarding drug use].
    Massó P
    Salud Colect; 2015 Sep; 11(3):381-99. PubMed ID: 26418094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
    Moore D; Fraser S; Törrönen J; Tinghög ME
    Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting from an illegal-drug policy to a psychoactive substance policy.
    van der Linde F
    Soz Praventivmed; 2006; 51(3):128-9. PubMed ID: 17191533
    [No Abstract]   [Full Text] [Related]  

  • 4. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O; Demetrovics Z; van den Brink W; Schifano F
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug policy and Collective Health: necessary dialogues.
    Gomes-Medeiros D; Faria PH; Campos GWS; Tófoli LF
    Cad Saude Publica; 2019 Jul; 35(7):e00242618. PubMed ID: 31365702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of policy: understanding the process of policy development.
    Ryder D
    Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs, prisons, and harm reduction.
    Hughes R
    J Health Soc Policy; 2003; 18(2):43-54. PubMed ID: 15189795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New drug policies: the Geneva example].
    Mino A
    Psychiatr Enfant; 1994; 37(2):577-99. PubMed ID: 7878141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk environments and drug harms: a social science for harm reduction approach.
    Rhodes T
    Int J Drug Policy; 2009 May; 20(3):193-201. PubMed ID: 19147339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
    Faulkner-Gurstein R
    Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a sociology of normal substance use.
    Hammersley R
    Int J Drug Policy; 2011 Nov; 22(6):413-4. PubMed ID: 22104588
    [No Abstract]   [Full Text] [Related]  

  • 14. Erasing pleasure from public discourse on illicit drugs: on the creation and reproduction of an absence.
    Moore D
    Int J Drug Policy; 2008 Oct; 19(5):353-8. PubMed ID: 17728122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug effects, performativity and the law.
    Race K
    Int J Drug Policy; 2011 Nov; 22(6):410-2. PubMed ID: 22056290
    [No Abstract]   [Full Text] [Related]  

  • 16. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?
    Sheridan J; Butler R
    Int J Drug Policy; 2010 Jan; 21(1):77-81. PubMed ID: 19321329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The law, social control, and drug policy: models, factors, and processes.
    Erickson PG
    Int J Addict; 1993 Oct; 28(12):1155-76. PubMed ID: 8282448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: the three phases of harm reduction. An examination of emerging concepts, methodologies, and critiques.
    Erickson PG
    Subst Use Misuse; 1999 Jan; 34(1):1-7. PubMed ID: 10052386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.